KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Medpace Holdings (MEDP) Accumulated Depreciation & Amortization: 2015-2024

  • Medpace Holdings' Accumulated Depreciation & Amortization rose 24.51% to $98.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $291.5 million, marking a year-over-year increase of 25.79%. This contributed to the annual value of $98.9 million for FY2024, which is 24.51% up from last year.
  • Medpace Holdings' Accumulated Depreciation & Amortization amounted to $98.9 million in Q4 2024, which was up 24.51% from $79.4 million recorded in Q4 2023.
  • Over the past 5 years, Medpace Holdings' Accumulated Depreciation & Amortization peaked at $98.9 million during Q4 2024, and registered a low of $39.1 million during Q4 2020.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $79.4 million (2023), whereas its average is $80.1 million.
  • Data for Medpace Holdings' Accumulated Depreciation & Amortization shows a peak YoY spiked of 30.67% (in 2021) over the last 5 years.
  • Over the past 5 years, Medpace Holdings' Accumulated Depreciation & Amortization (Quarterly) stood at $39.1 million in 2020, then soared by 30.67% to $51.1 million in 2021, then climbed by 21.56% to $62.1 million in 2022, then rose by 27.83% to $79.4 million in 2023, then climbed by 24.51% to $98.9 million in 2024.
  • Its last three reported values are $98.9 million in Q4 2024, $79.4 million for Q4 2023, and $62.1 million during Q4 2022.